Nohla Therapeutics Overview

  • Founded
  • 2015

Founded
  • Status
  • Out of Business

  • Employees
  • 43

Employees
  • Latest Deal Type
  • Out of Business

Nohla Therapeutics General Information

Description

Developer of universal, off-the-shelf cell therapies intended to help treat hematologic malignancies and other critical diseases. The company's products are based on a unique umbilical cord blood expansion platform, providing doctors the functional support of bone marrow in response to each patient's unique blood-production needs, without any requirement for HLA matching.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 1600 Fairview Avenue East
  • Suite 100
  • Seattle, WA 98102
  • United States
+1 (206) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nohla Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 01-Nov-2019 00000 Completed Out of Business
4. Early Stage VC (Series B) 12-Jul-2018 0000 00000 Completed Clinical Trials - Phase 2
3. Grant 28-Sep-2017 00.00 000.00 Completed Startup
2. Early Stage VC (Series A) 29-Nov-2016 $43.5M $64.5M 00000 Completed Startup
1. Corporate 24-Dec-2015 $21M $21M Completed Startup
To view Nohla Therapeutics’s complete valuation and funding history, request access »

Nohla Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 000,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A1 000,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.00
To view Nohla Therapeutics’s complete cap table history, request access »

Nohla Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of universal, off-the-shelf cell therapies intended to help treat hematologic malignancies and other critical
Biotechnology
Seattle, WA
43 As of 2018
00000
00000000 00 00000

000000

d tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercita
0000 000000000
Philadelphia, PA
00 As of 0000
00000
0000 0000-00-00
00000000000 00000

000000

aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cil
0000 000000000
Rockville, MD
0 As of 0000
000.00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nohla Therapeutics Competitors (49)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Carisma Therapeutics Venture Capital-Backed Philadelphia, PA 00 00000 00000000000 00000
000000000 00000000 Venture Capital-Backed Rockville, MD 0 000.00 0000000000 0 000.00
00 00000000 Formerly VC-backed Glasgow, United Kingdom 00 000.00 00000000 000.00
000000 Venture Capital-Backed Utrecht, Netherlands 00 00.000 0000000000 0 00.000
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
You’re viewing 5 of 49 competitors. Get the full list »

Nohla Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial